Table 4.
Summary of the prevalence of MMTV detection of investigated cases and controls.
| Study | MMTV-Positive Cases/Total | MMTV-Positive Controls/Total | Statistically Significant? Y/N (p-Value) |
|---|---|---|---|
| Khalid, 2021 [99] | 69/105 (65%) | 2/15 (13%) § | Yes (p = 0.0001) |
| De Sousa Pereira, 2020 [100] | 41/217 (19%) | 30/196 (15%) § | No (p = 0.3624) |
| Seo, 2019 [102] | 12/128 (9%) | 0/128 (0%) § | Yes (p = 0.0004) |
| Al Dossary, 2018 [103] | 9/103 (9%) | 0/51 *,#,& | Yes (p = 0.0301) |
| Shariatpanahi, 2017 [105] | 19/59 (32%) | 3/59 (5%) # | Yes (p < 0.001) |
| Reza, 2015 [106] | 12/100 (12%) | 0/100 (0%) § | Yes (p = 0.0003) |
| Ahangar Oskouee, 2014 [107] | 0/65 (0%) | 0/65 # | // |
| Morales-Sánchez, 2013 [109] | 0/86 (0%) | 0/65 (0%) § | // |
| Glenn, 2012 [17] | 39/50 (78%) with liquid PCR 5/27 (19%) with IS-PCR |
13/40 (32%) ^ with liquid PCR 3/18 (17%) ^ with IS-PCR |
Yes, with liquid PCR (p = 0.0001) No with IS-PCR (p = 1.0000) |
| Lawson, 2010 [113] | 33/74 (54%) with liquid PCR 5/27 (19%) by IS-PCR |
0/29 (0%) § with liquid PCR 3/18 (17%) § with IS-PCR |
Yes with liquid PCR (p = 0.0001) No with IS-PCR (p = 1.0000) |
| Hachana, 2008 [115] | 17/122 (14%) | 0/122 (0%) § | Yes (p < 0.0001) |
* fibroadenomas, # unspecified benign lesions, § normal breast tissue from the same patient, ^ normal breast tissue from healthy patients, & fibrocystic disorder, //, data not available.